Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 4/2014

01.08.2014 | Commentary

Measuring the impact of long-term medicines use from the patient perspective

verfasst von: Janet Krska, Charles W. Morecroft, Philip H. Rowe, Helen Poole

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Polypharmacy is increasing, seemingly inexorably, and inevitably the associated difficulties for individual patients of coping with multiple medicines rise with it. Using medicines is one aspect of the burden associated with living with a chronic condition. It is becoming increasingly important to measure this burden particularly that relating to multiple long-term medicines. Pharmacists and other health professionals provide a myriad of services designed to optimise medicines use, ostensibly aiming to help and support patients, but in reality many such services focus on the medicines, and seek to improve adherence rather than reducing the burden for the patient. We believe that the patient perspective and experience of medicines use is fundamental to medicines optimisation and have developed an instrument which begins to quantify these experiences. The instrument, the Living with Medicines Questionnaire, was generated using qualitative findings with patients, to reflect their perspective. Further development is ongoing, involving researchers in multiple countries.
Literatur
1.
Zurück zum Zitat Salisbury C, Johnson L, Purgy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care. A retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.PubMedCentralPubMedCrossRef Salisbury C, Johnson L, Purgy S, Valderas JM, Montgomery AA. Epidemiology and impact of multimorbidity in primary care. A retrospective cohort study. Br J Gen Pract. 2011;61(582):e12–21.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Moynihan R, Doust J, Henry D. Preventing over-diagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.PubMedCrossRef Moynihan R, Doust J, Henry D. Preventing over-diagnosis: how to stop harming the healthy. BMJ. 2012;344:e3502.PubMedCrossRef
3.
Zurück zum Zitat Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28:159–72.PubMedCrossRef Hovstadius B, Petersson G. Factors leading to excessive polypharmacy. Clin Geriatr Med. 2012;28:159–72.PubMedCrossRef
4.
Zurück zum Zitat Duerden M, Avery AJ, Payne R. Polypharmacy and medicines optimisation—making it safe and sound. London: The King’s Fund; 2013. Duerden M, Avery AJ, Payne R. Polypharmacy and medicines optimisation—making it safe and sound. London: The King’s Fund; 2013.
5.
Zurück zum Zitat Gnjidic D, Le Couter DG, Pearson S-A, McLachlan AJ, Viney R, Hilmer SN, Blyth FM, Joshy G, Banks E. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health. 2013;13:115. doi:10.1186/1471-2458-13-115.PubMedCentralPubMedCrossRef Gnjidic D, Le Couter DG, Pearson S-A, McLachlan AJ, Viney R, Hilmer SN, Blyth FM, Joshy G, Banks E. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health. 2013;13:115. doi:10.​1186/​1471-2458-13-115.PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Morgan T, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes JA. National census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196:50–3.PubMedCrossRef Morgan T, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes JA. National census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196:50–3.PubMedCrossRef
7.
Zurück zum Zitat Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated review. J Gerontol Nurs. 2005;31:4–11.PubMedCrossRef Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated review. J Gerontol Nurs. 2005;31:4–11.PubMedCrossRef
8.
Zurück zum Zitat May M, Montori V, Mair F. We need minimally disruptive medicine. BMJ. 2009;339:485–7.CrossRef May M, Montori V, Mair F. We need minimally disruptive medicine. BMJ. 2009;339:485–7.CrossRef
9.
Zurück zum Zitat Sav A, Kendall E, Mc Millan SS, Kelly F, Whitty JA, King MA, Wheeler AJ. ‘You say treatment, I say hard work’: treatment burden among people with chronic illness and their carers in Australia. Health Soc Care Commun. 2013;21(6):665–74. Sav A, Kendall E, Mc Millan SS, Kelly F, Whitty JA, King MA, Wheeler AJ. ‘You say treatment, I say hard work’: treatment burden among people with chronic illness and their carers in Australia. Health Soc Care Commun. 2013;21(6):665–74.
10.
Zurück zum Zitat Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.PubMedCrossRef Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med. 2005;61(1):133–55.PubMedCrossRef
11.
Zurück zum Zitat Reeve E, Weiss MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriat Soc. 2013;61:1508–14.PubMedCrossRef Reeve E, Weiss MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriat Soc. 2013;61:1508–14.PubMedCrossRef
12.
Zurück zum Zitat Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011;9:95.PubMedCrossRef Olsson IN, Runnamo R, Engfeldt P. Medication quality and quality of life in the elderly, a cohort study. Health Qual Life Outcomes. 2011;9:95.PubMedCrossRef
13.
Zurück zum Zitat Morecroft CW, Cantrill J, Tully MP. Patients’ evaluation of the appropriateness of their hypertension management—a qualitative study. Res Soc Admin Pharm. 2006;2:186–211.CrossRef Morecroft CW, Cantrill J, Tully MP. Patients’ evaluation of the appropriateness of their hypertension management—a qualitative study. Res Soc Admin Pharm. 2006;2:186–211.CrossRef
14.
Zurück zum Zitat Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. I don’t know how many of these [medicines] are necessary. A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2008;74:135–41.PubMedCrossRef Moen J, Bohm A, Tillenius T, Antonov K, Nilsson JLG, Ring L. I don’t know how many of these [medicines] are necessary. A focus group study among elderly users of multiple medicines. Patient Educ Couns. 2008;74:135–41.PubMedCrossRef
15.
Zurück zum Zitat Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.PubMedCrossRef Krska J, Morecroft CW, Poole H, Rowe PH. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study. Int J Clin Pharm. 2013;35(6):1161–9.PubMedCrossRef
20.
Zurück zum Zitat Krska J, Rowe PH. Outcome measures: a sensitive approach. Int J Pharm Pract. 2010;18:125–7.PubMed Krska J, Rowe PH. Outcome measures: a sensitive approach. Int J Pharm Pract. 2010;18:125–7.PubMed
21.
Zurück zum Zitat Elliott RA, Marriott JL. Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.PubMedCentralPubMedCrossRef Elliott RA, Marriott JL. Standardised assessment of patients’ capacity to manage medications: a systematic review of published instruments. BMC Geriatr. 2009;9:27.PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Eton DT, Elraiyah TA, Yost KJ, Ridgeway LJ, Johnson A, Eggington JS, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.PubMedCentralPubMedCrossRef Eton DT, Elraiyah TA, Yost KJ, Ridgeway LJ, Johnson A, Eggington JS, et al. A systematic review of patient-reported measures of burden of treatment in three chronic diseases. Patient Relat Outcome Meas. 2013;4:7–20.PubMedCentralPubMedCrossRef
23.
Zurück zum Zitat Blalock SJ, Patel RA. Drug therapy concerns questionnaire: Initial development and refinement. J Am Pharm Assoc. 2005;45:160–9.CrossRef Blalock SJ, Patel RA. Drug therapy concerns questionnaire: Initial development and refinement. J Am Pharm Assoc. 2005;45:160–9.CrossRef
24.
Zurück zum Zitat Rowe PH, Krska J. Satisfaction with medicines: the views of elderly patients. Int J Pharm Pract. 2008;16(suppl 1):A3. Rowe PH, Krska J. Satisfaction with medicines: the views of elderly patients. Int J Pharm Pract. 2008;16(suppl 1):A3.
25.
Zurück zum Zitat Krska J, Morecroft CW, Poole H, Rowe PH. A novel instrument to measure medicines-related quality of life. Int J Clin Pharm. 2013;35:488.CrossRef Krska J, Morecroft CW, Poole H, Rowe PH. A novel instrument to measure medicines-related quality of life. Int J Clin Pharm. 2013;35:488.CrossRef
Metadaten
Titel
Measuring the impact of long-term medicines use from the patient perspective
verfasst von
Janet Krska
Charles W. Morecroft
Philip H. Rowe
Helen Poole
Publikationsdatum
01.08.2014
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 4/2014
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-9970-5

Weitere Artikel der Ausgabe 4/2014

International Journal of Clinical Pharmacy 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.